おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Qihan Biotech
company
About
Qihan Biotech is a gene-editing organ transplantation technology developer.
- 251 - 500
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $7.80M
- Industries
- Biotechnology,Clinical Trials,Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2017
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$100.30M
Qihan Biotech has raised a total of
$100.30M
in funding over 2 rounds. Their latest funding was raised on
Mar 29, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 29, 2021 | Series A | $67M | 1 |
Lilly Asia Ventures
|
— | Detail |
| Sep 22, 2019 | Series A | $25.50M | 1 | — | — | Detail |
| Jul 23, 2018 | Series A | $7.80M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Qihan Biotech has made 1 investments. Their most recent investment was on
Aug 19, 2019, when ResortPass raised $9M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Aug 19, 2019
ResortPass
|
Series A | $9M | Hospitality | — |
Investors
Number of Lead Investors
Number of Investors
1
3
Qihan Biotech is funded by 3 investors.
Lilly Asia Ventures
and Xinyi Biology
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Series A |
|
|
— | Series A |
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
